Sapsutthipas, S. et al.: CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors. PLoS ONE 8: e53920, 2013.
Boonchawalit, S. et al.: Molecular evolution of HIV-1 CRF01_AE Env in Thai patients. PLoS ONE 6: e27098, 2011.
Isarangkura-na-ayuthaya, P. et al.: Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01_AE integrase derived from drug-naïve Thai patients. AIDS Res. Hum. Retroviruses 26: 1341-1343, 2010.
Soonthornsata, B. et al.: Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41. Virology 405: 157-164, 2010.
Utachee, P. et al.: Two N-linked glycosylation sites in V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for CD4 binding domain. J. Virol. 84: 4311-4320, 2010.
|
